BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 23947360)

  • 1. Immunity to viruses: learning from successful human vaccines.
    Pulendran B; Oh JZ; Nakaya HI; Ravindran R; Kazmin DA
    Immunol Rev; 2013 Sep; 255(1):243-55. PubMed ID: 23947360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate and adaptive immune responses to viral infection and vaccination.
    Aoshi T; Koyama S; Kobiyama K; Akira S; Ishii KJ
    Curr Opin Virol; 2011 Oct; 1(4):226-32. PubMed ID: 22440781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines.
    Mok DZL; Chan KR
    Viruses; 2020 May; 12(5):. PubMed ID: 32397218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD; de Vries P
    Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some unmet challenges in the immunology of viral infections.
    Rouse BT; Lukacher AE
    Discov Med; 2010 Oct; 10(53):363-70. PubMed ID: 21034678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model.
    Yuan L; Saif LJ
    Vet Immunol Immunopathol; 2002 Sep; 87(3-4):147-60. PubMed ID: 12072229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate and adaptive immune responses in respiratory virus infection: implications for the clinic.
    Stambas J; Lu C; Tripp RA
    Expert Rev Respir Med; 2020 Nov; 14(11):1141-1147. PubMed ID: 32762572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wanted, dead or alive: new viral vaccines.
    Amanna IJ; Slifka MK
    Antiviral Res; 2009 Nov; 84(2):119-30. PubMed ID: 19733596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-based vaccine development and evaluation against viral infections in pigs.
    Dhakal S; Renukaradhya GJ
    Vet Res; 2019 Nov; 50(1):90. PubMed ID: 31694705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development.
    Balz K; Trassl L; Härtel V; Nelson PP; Skevaki C
    Front Immunol; 2020; 11():513. PubMed ID: 32296430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of Cellular Immune Response to Viral Infection and Vaccination.
    Bouwman W; Verhaegh W; Holtzer L; van de Stolpe A
    Front Immunol; 2020; 11():575074. PubMed ID: 33193365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity.
    Pérez-Girón JV; Gómez-Medina S; Lüdtke A; Munoz-Fontela C
    J Vis Exp; 2015 Jun; (100):e52803. PubMed ID: 26168339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.
    Kulkarni RR; Rasheed MA; Bhaumik SK; Ranjan P; Cao W; Davis C; Marisetti K; Thomas S; Gangappa S; Sambhara S; Murali-Krishna K
    J Virol; 2014 Dec; 88(24):13990-4001. PubMed ID: 25253340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
    Cavanagh D
    Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken.
    Matoo JJ; Bashir K; Kumar A; Krishnaswamy N; Dey S; Chellappa MM; Ramakrishnan S
    Microb Pathog; 2018 Jun; 119():119-124. PubMed ID: 29635053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems integration of innate and adaptive immunity.
    Zak DE; Aderem A
    Vaccine; 2015 Sep; 33(40):5241-8. PubMed ID: 26102534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-defective viruses as vaccines and vaccine vectors.
    Dudek T; Knipe DM
    Virology; 2006 Jan; 344(1):230-9. PubMed ID: 16364753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.